Similar articles for PMID: 26635282

Year	Number of Results
1976	1
1977	1
1981	1
1990	1
1995	2
1996	1
1997	4
1998	1
1999	2
2000	1
2001	1
2003	1
2004	2
2006	2
2007	3
2008	2
2009	4
2010	3
2011	3
2012	3
2013	4
2014	9
2015	12
2016	9
2017	8
2018	9
2019	5
2020	4
2022	0

1

Low Signals on T2* and SWI Sequences in Patients with MS with Progressive Multifocal Leukoencephalopathy.

Labauge P, Carra-Dalliere C, Ayrignac X, Menjot de Champfleur N. Labauge P, et al. AJNR Am J Neuroradiol. 2016 Feb;37(2):E11. doi: 10.3174/ajnr.A4632. Epub 2015 Dec 3. AJNR Am J Neuroradiol. 2016. PMID: 26635282 Free PMC article. No abstract available.

2

Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor.

Thurnher MM, Boban J, Rieger A, Gelpi E. Thurnher MM, et al. AJNR Am J Neuroradiol. 2019 Jun;40(6):994-1000. doi: 10.3174/ajnr.A6072. Epub 2019 May 23. AJNR Am J Neuroradiol. 2019. PMID: 31122919 Free PMC article.

3

Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.

Carra-Dalliere C, Menjot de Champfleur N, Deverdun J, Ayrignac X, Nerrant E, Makinson A, Casanova ML, Labauge P. Carra-Dalliere C, et al. J Neuroradiol. 2016 Feb;43(1):6-10. doi: 10.1016/j.neurad.2015.08.001. Epub 2015 Oct 23. J Neuroradiol. 2016. PMID: 26475668

4

Low-signal-intensity rim on susceptibility-weighted imaging is not a specific finding to progressive multifocal leukoencephalopathy.

Umino M, Maeda M, Ii Y, Tomimoto H, Sakuma H. Umino M, et al. J Neurol Sci. 2016 Mar 15;362:155-9. doi: 10.1016/j.jns.2016.01.036. Epub 2016 Jan 22. J Neurol Sci. 2016. PMID: 26944139

5

Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate.

Dammeier N, Schubert V, Hauser TK, Bornemann A, Bischof F. Dammeier N, et al. BMC Neurol. 2015 Jul 8;15:108. doi: 10.1186/s12883-015-0363-8. BMC Neurol. 2015. PMID: 26152311 Free PMC article.

6

Low signal intensity in U-fiber identified by susceptibility-weighted imaging in two cases of progressive multifocal leukoencephalopathy.

Miyagawa M, Maeda M, Umino M, Kagawa K, Nakamichi K, Sakuma H, Tomimoto H. Miyagawa M, et al. J Neurol Sci. 2014 Sep 15;344(1-2):198-202. doi: 10.1016/j.jns.2014.06.018. Epub 2014 Jun 19. J Neurol Sci. 2014. PMID: 24972818

7

Progressive multifocal leukoencephalopathy in a child with acquired immunodeficiency syndrome (AIDS).

Araujo AP, Pereira HS, Oliveira RH, Frota AC, Esperança JC, Duarte F. Araujo AP, et al. Arq Neuropsiquiatr. 1997 Mar;55(1):122-5. doi: 10.1590/s0004-282x1997000100019. Arq Neuropsiquiatr. 1997. PMID: 9332571

8

Detection of JC virus DNA by polymerase chain reaction in patients with progressive multifocal leukoencephalopathy.

Telenti A, Aksamit AJ Jr, Proper J, Smith TF. Telenti A, et al. J Infect Dis. 1990 Oct;162(4):858-61. doi: 10.1093/infdis/162.4.858. J Infect Dis. 1990. PMID: 2169500

9

Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?

Maillart E, Louapre C, Lubetzki C, Papeix C. Maillart E, et al. Mult Scler. 2014 Apr;20(4):505-9. doi: 10.1177/1352458513516530. Epub 2013 Dec 23. Mult Scler. 2014. PMID: 24367037

10

Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database.

Melis M, Biagi C, Småbrekke L, Nonino F, Buccellato E, Donati M, Vaccheri A, Motola D. Melis M, et al. CNS Drugs. 2015;29(10):879-91. doi: 10.1007/s40263-015-0286-3. CNS Drugs. 2015. PMID: 26507833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed